IgG4 ‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets
Allergy · 2025-10 · 80 (10) · 2738-2754
DOI: 10.1111/all.16686 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Allergy, online erschienen am 11.08.2025. Verfasst von Louisa Tedesco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia. Hauptthemen laut MEDLINE: Immunoglobulin G4-Related Disease, Immunoglobulin G, Genetic Variation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
IgG4, the least abundant IgG subclass in humans, is increasingly recognised for its involvement in allergic and autoimmune pathologies. Its unique properties, such as the tendency to form half‐molecules (one heavy chain and one light chain) and its generally non‐inflammatory nature, distinguish it from other IgG subclasses. Its role in immune dysregulation is further underscored by a distinct disease entity called IgG4‐related disease (IgG4‐RD), a systemic fibroinflammatory disorder characterised by IgG4 + plasma cell tissue infiltration, storiform fibrosis and obliterative phlebitis, reflecting a dysregulated immune response affecting multiple organs. This review examines the current understanding of IgG4, its emerging roles in immune dysregulation and IgG4‐RD, including clinical manifestations and treatment options. We also discuss the recent advances in understanding the genetic underpinnings of IgG4‐RD, highlighting the significance of germline gene variants and implicated immune cell types. Finally, we explore future research directions, emphasising the need for deeper insights into pathogenesis, specific biomarkers and optimised treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.
- Department of Clinical Immunology and Allergy, Flinders Medical Centre, Bedford Park, South Australia, Australia.
- School of Medicine and Biomedical Sciences, Flinders University, Bedford Park, South Australia, Australia.
- Can Sucak Research Laboratory for Translational Immunology, Hacettepe University, Ankara, Türkiye.
- Institute of Child Health, Hacettepe University, Ankara, Türkiye.
- Faculty of Medicine, Division of Pediatric Allergy and Immunology, Marmara University, Istanbul, Türkiye.
ORCID-Profile: Louisa Tedesco, Syed B Ali, Baran Erman, Safa Baris, Gökhan Cildir
Förderung
- National Health and Medical Research Council (NHMRC)
Zitieren
APA
Tedesco, L., Ali, S. B., Erman, B., Baris, S., Pant, H., Hissaria, P., Bilginer, Y., Tumes, D. J., & Cildir, G. (2025). IgG4 ‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets. Allergy, 80(10), 2738-2754. https://doi.org/10.1111/all.16686
Vancouver
Tedesco L, Ali SB, Erman B, Baris S, Pant H, Hissaria P, et al. IgG4 ‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets. Allergy. 2025;80(10):2738-2754. doi:10.1111/all.16686
BibTeX
@article{Tedesco2025,
author = {Tedesco, Louisa and Ali, Syed B and Erman, Baran and Baris, Safa and Pant, Harshita and Hissaria, Pravin and Bilginer, Yelda and Tumes, Damon J and Cildir, Gökhan},
title = {IgG4 ‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets},
journal = {Allergy},
year = {2025},
volume = {80},
number = {10},
pages = {2738--2754},
doi = {10.1111/all.16686}
}
EUVIMED